COMPANY

Sinopia Biosciences

HQ: San Diego, CA source · sinopiabio.com ↗ · West Coast

Location: San Diego, CA · source · Oct 13, 2026

Profile checked Oct 10, 2026

Sinopia Biosciences develops deep learning algorithms to analyze complex biological data, revealing therapeutic targets and drug candidates. From company website Source · checked 2026-10-19

Sources for this description (1)

Sinopia Biosciences develops deep learning algorithms to analyze complex biological data, revealing therapeutic targets and drug candidates.
- “We develop advanced deep learning algorithms to analyze complex biological data, revealing novel therapeutic targets and drug candidates.” https://www.sinopiabio.com/about (2026-10-19)

20NIH grants

Funding and NIH signals

NIH award NIH awarded $1.48M (SBIR Phase II 2R44GM154585-02, competing renewal, notice Sep 10, 2026); 3 NIH awards totaling $4.59M in the last 12 months. NIH RePORTER 2R44GM154585-02 (Sep 10, 2026)
Evidence (3 events)
- Sep 10, 2026 · NIH RePORTER 2R44GM154585-02
  Organization: SINOPIA BIOSCIENCES, INC.; City/State: SAN DIEGO, CA; Project number: 2R44GM154585-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-10; FY total cost (award amount): 1477110; Administering IC: National Institute of General Medical Sciences; Project title: Development and Validation of Data Standards and Computational Methods for Large Scale Metabolomics Data Analysis for Data Driven Drug Discovery; Organization type: Domestic For-Profits
- Sep 7, 2026 · NIH RePORTER 2R44NS124398-04A1
  Organization: SINOPIA BIOSCIENCES, INC.; City/State: SAN DIEGO, CA; Project number: 2R44NS124398-04A1; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-07; FY total cost (award amount): 3000000; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: Preclinical development of a novel therapeutic for Parkinson's disease; Organization type: Domestic For-Profits
- Aug 10, 2026 · NIH RePORTER 5R43CA295316-02
  Organization: SINOPIA BIOSCIENCES, INC.; City/State: SAN DIEGO, CA; Project number: 5R43CA295316-02; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-08-10; FY total cost (award amount): 114274; Administering IC: National Cancer Institute; Project title: Development of a metabolomics enabled AI/ML platform for discovery of new treatments to enhance drug sensitivity in cancer; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Raises and deals from press releases

Deal Ono Pharmaceutical deal · amount not disclosed · announced Mar 3, 2026 Company release ↗
Source quote
- Mar 3, 2026 · Company release ↗
  “SAN DIEGO, March 03, 2026 - Sinopia Biosciences, Inc. , a biotechnology company advancing novel therapeutics discovered using its proprietary LEADS® (LEarn And DiScover) drug discovery platform, today announced a target discovery collaboration with Ono Pharmaceutical Co.”

From the company’s own releases; this list is partial. All raises and deals

Timeline

Sep 10, 2026 Grant Government grant — SBIR: $1.48M (annual award, as published), announced Sep 10, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
Sep 7, 2026 Grant Government grant — SBIR: $3M (annual award, as published), announced Sep 7, 2026. Agency: NIH/NINDS. Source: government award database. source ↗
Aug 10, 2026 Grant Government grant — SBIR: $114,274 (annual award, as published), announced Aug 10, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Jul 9, 2026 Raise Private equity round — Seed: amount not published, announced Jul 9, 2026. Source: company's own press page. source ↗ · Form D filed Jul 16, 2026 SEC Form D ↗
Mar 3, 2026 Partnership Partnership / licensing announced Mar 3, 2026. Source: company's own press page. source ↗
Dec 30, 2025 Grant Government grant announced Dec 30, 2025. Source: company's own press page. source ↗
Sep 18, 2025 Grant Government grant — SBIR: $285,599 (annual award, as published), announced Sep 18, 2025. Agency: NIH/NCI. Source: government award database. source ↗
Aug 15, 2025 Grant Government grant — SBIR: $39,650 (annual award, as published), announced Aug 15, 2025. Agency: NIH/NIDCR. Source: government award database. source ↗
Aug 4, 2025 Grant Government grant — SBIR: $849,193 (annual award, as published), announced Aug 4, 2025. Agency: NIH/NIDCR. Source: government award database. source ↗
Jul 23, 2025 Grant Government grant — SBIR: $350,000 (annual award, as published), announced Jul 23, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗

Funding

Raised: amount not published. Last 2 years.

Jul 9, 2026 Private equity round — Seed: amount not published, announced Jul 9, 2026. Source: company's own press page. source ↗ · Form D filed Jul 16, 2026 SEC Form D ↗
Mar 3, 2026 Partnership / licensing announced Mar 3, 2026. Source: company's own press page. source ↗
Sep 10, 2026 Government grant — SBIR: $1.48M (annual award, as published), announced Sep 10, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
Sep 7, 2026 Government grant — SBIR: $3M (annual award, as published), announced Sep 7, 2026. Agency: NIH/NINDS. Source: government award database. source ↗
Aug 10, 2026 Government grant — SBIR: $114,274 (annual award, as published), announced Aug 10, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Dec 30, 2025 Government grant announced Dec 30, 2025. Source: company's own press page. source ↗
Sep 18, 2025 Government grant — SBIR: $285,599 (annual award, as published), announced Sep 18, 2025. Agency: NIH/NCI. Source: government award database. source ↗
Aug 15, 2025 Government grant — SBIR: $39,650 (annual award, as published), announced Aug 15, 2025. Agency: NIH/NIDCR. Source: government award database. source ↗
Aug 4, 2025 Government grant — SBIR: $849,193 (annual award, as published), announced Aug 4, 2025. Agency: NIH/NIDCR. Source: government award database. source ↗
Jul 23, 2025 Government grant — SBIR: $350,000 (annual award, as published), announced Jul 23, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗

NIH awards 20

Annual award amounts. Total $13.6M.

Sep 4, 2024 NIH award 2R44DE031464-02 FY2024: $1,493,635 awarded for that fiscal year; activity R44 (SBIR); PI LLOYD, COLTON JOSEPH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Preclinical assessment of a nov source ↗
Apr 18, 2024 NIH award 1R43GM154585-01 FY2024: $350,000 awarded for that fiscal year; activity R43 (SBIR); PI BLOEM, BERNARD; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Development and validation of data stan source ↗
Mar 1, 2024 NIH award 5R44NS124398-03 FY2024: $1,282,299 awarded for that fiscal year; activity R44 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Preclinical development of a novel t source ↗
Aug 30, 2023 NIH award 3R44NS124398-02S1 FY2023: $99,900 awarded for that fiscal year; activity R44 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Preclinical development of a novel th source ↗
Mar 20, 2023 NIH award 4R44NS124398-02 FY2023: $1,461,860 awarded for that fiscal year; activity R44 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Preclinical development of a novel t source ↗
Sep 20, 2022 NIH award 1R43DE031464-01A1 FY2022: $318,284 awarded for that fiscal year; activity R43 (SBIR); PI LLOYD, COLTON JOSEPH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Preclinical assessment of a nov source ↗
Feb 11, 2022 NIH award 5R44GM130268-03 FY2022: $871,587 awarded for that fiscal year; activity R44 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Development of a metabolomics and mach source ↗
Sep 17, 2021 NIH award 1R44NS124398-01 FY2021: $577,562 awarded for that fiscal year; activity R44 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Preclinical development of a novel the source ↗
Feb 5, 2021 NIH award 2R44GM130268-02 FY2021: $1,335,997 awarded for that fiscal year; activity R44 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Development of a metabolomics and ma source ↗
May 1, 2020 NIH award 5R44GM121117-03 FY2020: $754,478 awarded for that fiscal year; activity R44 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Developing a systems biology platform source ↗
Apr 26, 2019 NIH award 2R44GM121117-02 FY2019: $802,538 awarded for that fiscal year; activity R44 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Developing a systems biology platform source ↗
Mar 5, 2019 NIH award 1R43HL146014-01A1 FY2019: $224,284 awarded for that fiscal year; activity R43 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Improving safety and efficacy of pla source ↗
Aug 29, 2018 NIH award 1R43GM130268-01 FY2018: $442,427 awarded for that fiscal year; activity R43 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Development of a metabolomics and mach source ↗
Mar 21, 2018 NIH award 5R44HL127843-03 FY2018: $428,727 awarded for that fiscal year; activity R44 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Improving safety and efficacy of plate source ↗
Jun 14, 2017 NIH award 2R44HL127843-02 FY2017: $1,099,022 awarded for that fiscal year; activity R44 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Improving safety and efficacy of pla source ↗
May 26, 2017 NIH award 5R44HL123074-03 FY2017: $443,351 awarded for that fiscal year; activity R44 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Improving red blood cell transfusion t source ↗
Sep 13, 2016 NIH award 1R43GM121117-01 FY2016: $190,634 awarded for that fiscal year; activity R43 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Developing a Systems Biology Platform source ↗
Aug 15, 2016 NIH award 2R44HL123074-02 FY2016: $1,029,290 awarded for that fiscal year; activity R44 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Improving red blood cell transfusion source ↗
Jun 30, 2015 NIH award 1R43HL127843-01A1 FY2015: $223,582 awarded for that fiscal year; activity R43 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Improving safety and efficacy of pla source ↗
Jul 23, 2014 NIH award 1R43HL123074-01 FY2014: $150,000 awarded for that fiscal year; activity R43 (SBIR); PI BORDBAR, AARASH; recipient as written: SINOPIA BIOSCIENCES, INC., SAN DIEGO, CA. Improving red blood cell transfusion t source ↗